Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 8—August 2024
Research Letter

Emayella augustorita, New Member of Pasteurellaceae, Isolated from Blood Cultures of Septic Patient

Sylvain MeyerComments to Author , Valentin Tilloy, Sylvaine Durand-Fontanier, Thomas Lafon, Fabien Garnier, Christian Martin, Marie-Cécile Ploy, and Olivier Barraud
Author affiliations: Laboratoire de Bactériologie-Virologie-Hygiène, CHU Limoges, Limoges, France (S. Meyer, F. Garnier, C. Martin, M.-C. Ploy, O. Barraud); Université Limoges, UMR INSERM 1092, Limoges (S. Meyer, F. Garnier, C. Martin, M.-C. Ploy, O. Barraud); Centre National de Référence des Herpèsvirus, Limoges (V. Tilloy); Service de Chirurgie Digestive, CHU Limoges, Limoges (S. Durand-Fontanier); Service d’Accueil des Urgences, CHU Limoges, Limoges (T. Lafon).

Main Article

Table

MIC values observed for LIM206, Emayella augustorita, a novel bacteria of the Pasteurellaceae family recovered from a patient with sepsis, France*

Antibiotic PK/PD breakpoints, mg/L† MIC, mg/L
Amoxicillin 2–8 0.75
Amoxicillin + clavulanic acid 2–8 0.75
Piperacillin + tazobactam 8–16 1.0
Cefotaxime 1–2 0.032
Levofloxacin 0.5–1 0.064
Trimethoprim/sulfamethoxazole 0.5 0.004

*PK/PD, pharmacokinetics/pharmacodynamics. †All breakpoints were from EUCAST except for trimethoprim/sulfamethoxazole, which was epidemiologic cutoff value.

Main Article

Page created: May 24, 2024
Page updated: July 22, 2024
Page reviewed: July 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external